Histological changes of the feline cervix, endometrium and placenta after mid-gestational termination of pregnancy with aglepristone.
This study was conducted to investigate endometrial and placental structural changes that occurred in response to mid-gestational termination of pregnancy in queens using aglepristone, a progesterone receptor antagonist. Thirteen European Shorthair pregnant queens were either treated with aglepristone (10 mg/kg body weight; subcutaneously) twice on days 25 and 26 after first mating (am; group I; n = 9), or remained untreated and served as control (group II; n = 4). Queens of group I were ovariohysterectomized between days 30 and 41 am, either at the onset (n = 3) or during (n = 1) abortion and 12 h (n = 1), 24 h (n = 3) or 10 days after abortion (n = 1). Queens of group II were ovariohysterectomized on day 30 am. Tissue was collected from the cervix, and the interplacental zone as well as the paraplacenta/placental girdle of the uterus, subjected to standard histological procedures and evaluated using light microscopy. During abortion, gaps appeared within the paraplacenta and the placental girdle which were filled with blood, leading to an embryo-maternal disconnection. Blood was also observed within the uterine lumen as well as the interstitial mucosal stroma of the cervix and the placental girdle zone and probably originated from damaged venules, whilst arterioles remained intact. As the interval between abortion and surgery increased, the interstitial and luminal haemorrhages became less pronounced and completely disappeared except interstitial remnants 10 days after abortion. The endometrial regeneration was not fully completed on day 10 after abortion and a few cystically dilated glands were evident. In conclusion, abortion of queens through aglepristone given during mid-gestation is assumed to be the result of damage of uterine venules. This leads to an interstitial haemorrhages and bleeding into the uterine lumen, subsequently resulting in utero-placental detachment.
Georgiev
P
P
Department of Obstetrics, Gynaecology and Andrology, Faculty of Veterinary Medicine, Thrakia University, Stara Zagora, Bulgaria. plana@abv.bg
Wehrend
A
A
Penchev
G
G
Vodenicharov
A
A
Kauffold
J
J
Leiser
R
R
D000019:Abortifacient Agents / Q000494:pharmacology*; D000028:Abortion, Induced / Q000379:methods / Q000662:veterinary; D000034:Abortion, Veterinary / Q000139:chemically induced* / Q000473:pathology; D000818:Animals; D002415:Cats; D002584:Cervix Uteri / Q000098:blood supply / Q000473:pathology*; D004717:Endometrium / Q000473:pathology*; D004963:Estrenes / Q000494:pharmacology*; D005260:Female; D005865:Gestational Age; D007044:Hysterectomy / Q000662:veterinary; D010052:Ovariectomy / Q000662:veterinary; D010920:Placenta / Q000473:pathology*; D011247:Pregnancy
D000019:Abortifacient Agents; D004963:Estrenes; C419063:aglepristone